周围T细胞淋巴瘤:从生物研究到新疗法
Shingo Nakahata1,2, Kazuhiro Morishita1,3
1Division of Tumor and Cellular Biochemistry, Department of Medical Sciences, University of Miyazaki, Miyazaki 889-1692, Japan.
Cancers
|August 26, 2023
概括
本系列涵盖了外围T细胞淋巴瘤 (PTCL),提供国际专家的见解. 它包括对这些复杂的血液癌症的评论和原始研究.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
背景情况:
- 周围T细胞淋巴瘤 (PTCL) 是一组异质的侵袭性非霍奇金淋巴瘤.
- 目前对PTCL的理解和治疗仍然具有挑战性,因为它们的复杂性和稀有性.
研究的目的:
- 巩固和介绍PTCL研究和临床实践的最新进展.
- 为PTCL提供诊断,分类和治疗策略的全面概述.
主要方法:
- 四个专家评价和两个原创研究文章的汇编.
- 由该领域的领先国际权威机构对当前知识的综合.
主要成果:
- 该系列涉及PTCL分类和分子亚型的不断变化的景观.
- 它强调了PTCL新兴的治疗点和新的治疗方法.
结论:
- 这个集合为管理PTCL的临床医生和研究人员提供了宝贵的见解.
- 它强调需要继续进行研究,以改善PTCL患者的治疗结果.
更多相关视频
相关概念视频
Tumor Immunotherapy
556
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
556
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K


